Monitoring neonates for ototoxicity

19Citations
Citations of this article
135Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: Neonates admitted to the neonatal intensive care unit (NICU) are at greater risk of permanent hearing loss compared to infants in well mother and baby units. Several factors have been associated with this increased prevalence of hearing loss, including congenital infections (e.g. cytomegalovirus or syphilis), ototoxic drugs (such as aminoglycoside or glycopeptide antibiotics), low birth weight, hypoxia and length of stay. The aetiology of this increased prevalence of hearing loss remains poorly understood. Design: Here we review current practice and discuss the feasibility of designing improved ototoxicity screening and monitoring protocols to better identify acquired, drug-induced hearing loss in NICU neonates. Study sample: A review of published literature. Conclusions: We conclude that current audiological screening or monitoring protocols for neonates are not designed to adequately detect early onset of ototoxicity. This paper offers a detailed review of evidence-based research, and offers recommendations for developing and implementing an ototoxicity monitoring protocol for young infants, before and after discharge from the hospital.

Cite

CITATION STYLE

APA

Garinis, A. C., Kemph, A., Tharpe, A. M., Weitkamp, J. H., McEvoy, C., & Steyger, P. S. (2018). Monitoring neonates for ototoxicity. International Journal of Audiology, 57(sup4), S41–S48. https://doi.org/10.1080/14992027.2017.1339130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free